Olympus Corporation (OCPNF)

Market Cap	12.01B -21.6%
Revenue (ttm)	6.36B +1.3%
Net Income	428.74M -42.2%
EPS	0.38 -40.5%
Shares Out	n/a
PE Ratio	28.01
Forward PE	n/a
Dividend	0.19 (1.68%)
Ex-Dividend Date	Mar 30, 2026

Volume	10,100
Open	11.19
Previous Close	10.23
Day's Range	11.18 - 11.19
52-Week Range	8.00 - 14.00
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About Olympus

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology product...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1919
• Employees: 29,297
• Stock Exchange: OTCMKTS
• Ticker Symbol: OCPNF

Financial Performance

In fiscal year 2026, Olympus's revenue was 1.01 trillion, an increase of 1.34% compared to the previous year's 997.33 billion. Earnings were 68.17 billion, a decrease of -42.16%.

Financial numbers in JPY